Sign inJoin waitlistJoin the waitlist

Robert Bok

Professor · University of California (San Francisco) School of Medicine

Credentials: · · ·

History

University of California (San Francisco) School of Medicine
Present

Research

Metabolic imaging of patients with prostate cancer using hyperpolarized [1-¹³C]pyruvate
Science Translational Medicine · 2013 · 1,052 citations
Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading
Cancer Research · 2008 · 450 citations
Hyperpolarized 13C MRI: State of the Art and Future Directions
Review · Radiology · 2019 · 263 citations

Michael Ohliger
19 papers · 1 as a fellow
ZW
Zhen Wang
15 papers
Eric Small
13 papers
Rahul Aggarwal
11 papers
Susan Chang
11 papers
Robert Flavell
9 papers · 6 as a resident
Javier Villanueva-Meyer
8 papers
Andrei Goga
7 papers
HQ
Hecong Qin
5 papers
Maria Abraham
5 papers · 1 as a fellow
Brian Rini
4 papers
SS
Sanjay Sivalokanathan
4 papers · 4 as a resident

Grants

Novel Dual Agent HP C-13 MRI for Quantitative Imaging of Prostate Cancer Aggressiveness for Improved Biopsy Guidance
National Cancer Institute · R01
PI · $679.3K · University of California, San Francisco
2026–2031
Hyperpolarized C-13 MRI Techniques to Monitor Radiation Therapy Response in Prostate Cancer Patients
National Cancer Institute · R01
PI · $3.3M · University of California, San Francisco
2021–2027
Hyperpolarized C-13 MRI for Early Detection of Aggressive Prostate Cancer in Active Surveillance Patients
National Cancer Institute · U01
PI · $3.2M · University of California, San Francisco
2019–2025

Clinical trials

Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
Principal investigator · Recruiting · Phase 2
Robert Bok, MD, PhD
2024–2032
Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors
Principal investigator · Recruiting · Phase 1, Phase 2
Robert Bok, MD, PhD
2022–2027